We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept
LESVI Neuraxpharm offers a full manufacturing service for

FINISHED DOSAGE FORMS
OF PHARMACEUTICALS

that are customised and based upon our own developments

LESVI

is predominantly active in the CNS area; however our portfolio also consists of antiemetic, anti-infective, cardiovascular and pain products.

  • CNS PHARMACEUTICALS
    CNS
    PHARMACEUTICALS
    MORE
  • CNS NUTRACEUTICALS
    CNS
    NUTRACEUTICALS
    MORE
  • OTHER PHARMACEUTICALS
    OTHER
    PHARMACEUTICALS
    MORE

ORAL SOLID, STERILE AND NON-STERILE LIQUID FORMS

Expertise in oral solid dosage forms and in sterile and non-sterile liquid forms
MORE
Respiratory APIs

Lesvi is driven by Research and Development which is reflected in the NUMBER OF PRODUCTS SUPPLIED AND DISTRIBUTED
all over the world and in the loyalty of our clients
8 EU CEPs GRANTED

> 130

MOLECULES IN CNS

13 US DMFs filed

> 270

INVENTIONS

Japan 8 DMFs

> 1200

PATENTS WORLWIDE

>270 inventions generating >1.200 patents worldwide

 MORE
Neuraxpharm

Lesvi is part of Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of the central nervous system disorders (CNS). 

MORE

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.